drugset / Trial / NCT03303144
Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The main purpose is to establish the equivalence of Triferic iron administered via dialysate into the arterial blood line and into the venous blood line
Timeline
- Start
- 2017-10-01
- Primary completion
- 2017-12-28
- Completion
- 2017-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triferic | Other / unclassified | 6.5 mg | Other |